New cancer clinical trial: Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Published on: April 26, 2018 at 12:00PM
Condition:   Non-small Cell Lung Cancer
Interventions:   Radiation: hypofractionated radiotherapy;   Drug: nivolumab;   Drug: Ipilimumab
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting
https://ift.tt/2vQE0kd